loadpatents
Patent applications and USPTO patent grants for Suto; Mark J..The latest application filed is for "2,4,7-substituted-7-deaza-2'-deoxy-2'-fluoroarabinosyl nucleoside and nucleotide pro-drugs and uses thereof".
Patent | Date |
---|---|
Polymorophs of 5-aza-4'-thio-2'-deoxycytidine Grant 11,447,472 - Suto , et al. September 20, 2 | 2022-09-20 |
2,4,7-substituted-7-deaza-2'-deoxy-2'-fluoroarabinosyl Nucleoside And Nucleotide Pro-drugs And Uses Thereof App 20220251134 - Moukha-Chafiq; Omar ;   et al. | 2022-08-11 |
Thiarabine- And Thiarabine Prodrug-based Treatments App 20220241310 - Moukha-Chafiq; Omar ;   et al. | 2022-08-04 |
Compounds for the Treatment Of Acute and Chronic Kidney Disease App 20220153702 - Suto; Mark J. ;   et al. | 2022-05-19 |
Compounds for the Treatment Of Acute and Chronic Kidney Disease App 20220153695 - Suto; Mark J. ;   et al. | 2022-05-19 |
Polymorophs Of 5-aza-4'-thio-2'-deoxycytidine App 20220024903 - Suto; Mark J. ;   et al. | 2022-01-27 |
Substituted Quinazoline Sulfonamides As Thioredoxin Interacting Protein (txnip) Inhibitors App 20210369713 - Augelli-Szafran; Corinne E. ;   et al. | 2021-12-02 |
4'-thio-nucleotide And -nucleoside Prodrugs For The Treatment Of Cancer App 20210363170 - MOUKHACHAFIQ; Omar ;   et al. | 2021-11-25 |
Composition For Treating Blood Cancer Using 4'-thio-5-aza-2'-deoxycytidine And Uses Thereof App 20210330689 - Suto; Mark J. ;   et al. | 2021-10-28 |
Piperazine-2,5-diones As Tgf-beta Inhibitors App 20210323933 - Suto; Mark J. ;   et al. | 2021-10-21 |
Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors Grant 11,103,508 - Augelli-Szafran , et al. August 31, 2 | 2021-08-31 |
2,5-aryl-thiazole Analogs For The Treatment Of Neurodegenerative Diseases App 20210246110 - Suto; Mark J. ;   et al. | 2021-08-12 |
Benzoannulene derivatives as antiviral agents Grant 11,066,357 - Pathak , et al. July 20, 2 | 2021-07-20 |
Dipeptide analogs as TGF-beta inhibitors Grant 11,046,729 - Suto , et al. June 29, 2 | 2021-06-29 |
2-aminoaryl-5-aryloxazole Analogs For The Treatment Of Neurodegenerative Diseases App 20210188791 - Suto; Mark J. ;   et al. | 2021-06-24 |
Oxadiazoles and thiadiazoles as TGF-.beta. inhibitors Grant 11,033,535 - Suto , et al. June 15, 2 | 2021-06-15 |
Benzoannulene Derivatives As Antiviral Agents App 20210078937 - Pathak; Ashish Kumar ;   et al. | 2021-03-18 |
Oxadiazoles And Thiadiazoles As Tgf-beta Inhibitors App 20200222371 - Suto; Mark J. ;   et al. | 2020-07-16 |
Oxadiazoles and thiadiazoles as TGF-.beta. inhibitors Grant 10,653,682 - Suto , et al. | 2020-05-19 |
Substituted Quinazoline Sulfonamides As Thioredoxin Interacting Protein (txnip) Inhibitors App 20200038402 - Augelli-Szafran; Corinne E. ;   et al. | 2020-02-06 |
Dipeptide Analogs As Tgf-beta Inhibitors App 20190127420 - Suto; Mark J. ;   et al. | 2019-05-02 |
Oxadiazoles And Thiadiazoles As Tgf-beta Inhibitors App 20190125730 - Suto; Mark J. ;   et al. | 2019-05-02 |
Benzimidazole Compounds, Use As Inhibitors of WNT Signaling Pathway in Cancers, and Methods for Preparation Thereof App 20170210741 - AUGELLI-SZAFRAN; Corinne E. ;   et al. | 2017-07-27 |
Treatment Of Hepatitis B Viral App 20160303122 - Suto; Mark J. | 2016-10-20 |
Antiviral agents Grant 9,375,419 - Suto June 28, 2 | 2016-06-28 |
Antiviral Agents App 20160166557 - Suto; Mark J. | 2016-06-16 |
Compounds, compositions and methods for the treatment of diseases through inhibiting TGF-.beta. activity Grant 9,353,149 - Suto , et al. May 31, 2 | 2016-05-31 |
Heterocycles as potassium channel modulators Grant 9,018,208 - Christos , et al. April 28, 2 | 2015-04-28 |
Chemical compounds Grant 8,927,587 - Bagal , et al. January 6, 2 | 2015-01-06 |
Sodium Channel Inhibitors App 20140357685 - Beaudoin; Serge ;   et al. | 2014-12-04 |
Compounds, Compositions and Methods for the Treatment of Diseases Through Inhibiting TGF- Activity App 20140336115 - Suto; Mark J. ;   et al. | 2014-11-13 |
Sodium channel inhibitors Grant 8,853,250 - Beaudoin , et al. October 7, 2 | 2014-10-07 |
Chemical Compounds App 20130274243 - Bagal; Sharanjeet Kaur ;   et al. | 2013-10-17 |
Heterocycles As Potassium Channel Modulators App 20130143889 - Christos; Thomas Eugene ;   et al. | 2013-06-06 |
Heterocycles as potassium channel modulators Grant 8,431,608 - Christos , et al. April 30, 2 | 2013-04-30 |
Inhibitors of ion channels Grant 8,063,080 - Fulp , et al. November 22, 2 | 2011-11-22 |
Heterocycles as potassium channel modulators Grant 8,058,274 - Christos , et al. November 15, 2 | 2011-11-15 |
Calcium channel antagonists Grant 8,034,954 - Pacofsky , et al. October 11, 2 | 2011-10-11 |
Sodium Channel Inhibitors App 20100267782 - Beaudoin; Serge ;   et al. | 2010-10-21 |
Heterocycles As Potassium Channel Modulators App 20100240663 - Christos; Thomas Eugene ;   et al. | 2010-09-23 |
Inhibitors Of Ion Channels App 20100041707 - Fulp; Alan ;   et al. | 2010-02-18 |
Inhibitors of ion channels Grant 7,615,569 - Fulp , et al. November 10, 2 | 2009-11-10 |
Heterocycles As Potassium Channel Modulators App 20090062290 - Christos; Thomas Eugene ;   et al. | 2009-03-05 |
Calcium Channel Antagonists App 20070197523 - Pacofsky; Gregory J. ;   et al. | 2007-08-23 |
Calcium Channel Antagonists App 20070173504 - Pacofsky; Gregory J. ;   et al. | 2007-07-26 |
Inhibitors Of Ion Channels App 20070078145 - Fulp; Alan ;   et al. | 2007-04-05 |
Cytokine restraining agents Grant 6,245,738 - Suto , et al. June 12, 2 | 2001-06-12 |
Quinazoline analogs and related compounds and methods for treating inflammatory conditions Grant 5,939,421 - Palanki , et al. August 17, 1 | 1999-08-17 |
Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions Grant 5,935,966 - Suto , et al. August 10, 1 | 1999-08-10 |
Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions Grant 5,811,428 - Suto , et al. September 22, 1 | 1998-09-22 |
Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels Grant 5,786,332 - Girten , et al. July 28, 1 | 1998-07-28 |
Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels Grant 5,760,001 - Girten , et al. June 2, 1 | 1998-06-02 |
Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels Grant 5,726,156 - Girten , et al. March 10, 1 | 1998-03-10 |
Cytokine restraining agents Grant 5,420,109 - Suto , et al. May 30, 1 | 1995-05-30 |
Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process Grant 5,177,075 - Suto , et al. January 5, 1 | 1993-01-05 |
Quinolinecarboxylic acid antibacterial agents Grant 5,116,834 - Domagala , et al. May 26, 1 | 1992-05-26 |
Purine derivatives Grant 5,098,906 - Sircar , et al. March 24, 1 | 1992-03-24 |
Aziridino derivatives of nitroimidazoles and pharmaceutical compositions of selected derivatives Grant 5,036,096 - Suto July 30, 1 | 1991-07-30 |
2-oxazolidinone derivatives of nitroimidazoles and pharmaceutical compositions useful as sensitizing agents Grant 5,036,089 - Suto July 30, 1 | 1991-07-30 |
Purine derivatives Grant 4,921,859 - Sircar , et al. May 1, 1 | 1990-05-01 |
Purine derivatives Grant 4,806,642 - Sircar , et al. February 21, 1 | 1989-02-21 |
2-nitroimidazole derivatives useful as radiosensitizers for hypoxic tumor cells Grant 4,797,397 - Suto , et al. January 10, 1 | 1989-01-10 |
Substituted benzonitriles Grant 4,677,219 - Berman , et al. June 30, 1 | 1987-06-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.